BRANDI ALWINE: Open Payments
NPI 1770718173 · ANGOLA, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 21 payments from 10 companies in 2025. Trend: 2023 $215 · 2024 $73 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $196 |
| UROGEN PHARMA, INC. | 3 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| ABBVIE INC. | 2 | $38 |
| Teleflex LLC | 2 | $35 |
| Medtronic, Inc. | 1 | $34 |
| TOLMAR, INC. | 1 | $26 |
| 180 Medical, Inc. | 1 | $25 |
| QOL Medical, LLC | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: GEMTESA, JELMYTO, ENTYVIO, BARRIGEL, INTERSTIM, JATENZO, GATTEX, LUPRON DEPOT.
Industry payments across IN — which companies pay providers there.
